Immunization with a nontoxic mutant of staphylococcal enterotoxin A, SEAD227A, protects against enterotoxin-induced emesis in house musk shrews

Journal of Infectious Diseases

Volumn 199, Issue 3, 2009, Pages 302-310

  Hu, Dong Liang ^a   Omoe, Katsuhiko ^b   Sashinami, Hiroshi ^a   Shinagawa, Kunihiro ^b   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b IWATE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ENTEROTOXIN; SEAD 227A; STAPHYLOCOCCUS ENTEROTOXIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ESCHERICHIA COLI; FOOD POISONING; GEL; IMMUNIZATION; IMMUNODIFFUSION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SHREW; SITE DIRECTED MUTAGENESIS; SPLEEN CELL; VACCINATION; VOMITING; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; BASE SEQUENCE; CELL PROLIFERATION; ENTEROTOXINS; IMMUNE SERA; IMMUNIZATION; MUTATION; SHREWS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; SUPERANTIGENS; VOMITING;

EID: 58849150384     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/596065     Document Type: Article

References (43)

1. Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995; 8:411-26.
2. Le Loir Y, Baron F, Gautier M. Staphylococcus aureus and food poisoning. Genet Mol Res 2003; 2:63-76.
3. Do Carmo LS, Cummings C, Linardi VR, et al. A case study of a massive staphylococcal food poisoning incident. Foodborne Pathog Dis 2004; 1:241-6.
4. Antonsson P, Wingren AG, Hansson J, Kalland T, Varga M, Dohlsten M. Functional characterization of the interaction between the superantigen staphylococcal enterotoxin A and the TCR. J Immunol 1997; 158:4245-51.
5. Schad EM, Papageorgiou AC, Svensson LA, Acharya KR. A structural and functional comparison of staphylococcal enterotoxins A and C2 reveals remarkable similarity and dissimilarity. J Mol Biol 1997; 269:270-80.
6. + cells to bacterial superantigens. Eur J Immunol 1992; 22:1935-8.
7. Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13:16-34.
8. Omoe K, Imanishi K, Hu DL, et al. Biological properties of staphylococcal enterotoxin-like toxin type R. Infect Immun 2004; 72:3664-7.
9. Thomas DY, Jarraud S, Lemercier B, et al. Staphylococcal enterotoxin-like toxins U2 and V, two new staphylococcal superantigens arising from recombination within the enterotoxin gene cluster. Infect Immun 2006; 74:4724-34.
10. Schad EM, Zaitseva I, Zaitsev VN, et al. Crystal structure of the superantigen staphylococcal enterotoxin type A. EMBO J 1995; 14:3292-301.
11. Petersson K, Thunnissen M, Forsberg G, Walse B. Crystal structure of a SEA variant in complex with MHC class II reveals the ability of SEA to crosslink MHC molecules. Structure 2002; 10:1619-26.
12. Pontzer CH, Irwin MJ, Gascoigne NR, Johnson HM. T-cell antigen receptor binding sites for the microbial superantigen staphylococcal enterotoxin A. Proc Natl Acad Sci USA 1992; 89:7727-31.
13. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17:251-72.
14. Ulrich RG, Olson MA, Bavari S. Development of engineered vaccines effective against structurally related bacterial superantigens. Vaccine 1998; 16:1857-64.
15. Bavari S, Dyas B, Ulrich RG. Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A. J Infect Dis 1996; 174:338-45.
16. Woody MA, Krakauer T, Ulrich RG, Stiles BG. Differential immune responses to staphylococcal enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors. J Infect Dis 1998; 177:1013-22.
17. Lowell GH, Kaminski RW, Grate S, et al. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice. Infect Immun 1996; 64:1706-13.
18. Michie CA. Staphylococcal vaccines. Trends Immunol 2002; 23:461-3.
19. Hu DL, Cui JC, Omoe K, et al. A mutant of staphylococcal enterotoxin C devoid of bacterial superantigenic activity elicits a Th2 immune response for protection against Staphylococcus aureus infection. Infect Immun 2005; 73:174-80.
20. Hamad AR, Marrack P, Kappler JW. Transcytosis of staphylococcal superantigen toxins. J Exp Med 1997; 185:1447-54.
21. McKay DM. Bacterial superantigens: provocateurs of gut dysfunction and inflammation? Trends Immunol 2001; 22:497-501.
22. Hu DL, Omoe K, Shimoda Y, Nakane A, Shinagawa K. Induction of emetic response to staphylococcal enterotoxins in the house musk shrew (Suncus murinus). Infect Immun 2003; 71:567-70.
23. Van Gessel YA, Mani S, Bi S, et al. Functional piglet model for the clinical syndrome and postmortem findings induced by staphylococcal enterotoxin B. Exp Biol Med (Maywood) 2004; 229:1061-71.
24. Hu DL, Omoe K, Shimura H, Ono K, Sugii S, Shinagawa K. Emesis in the shrew mouse (Suncus murinus) induced by peroral and intraperitoneal administration of staphylococcal enterotoxin A. J Food Prot 1999; 62:1350-3.
25. Stiles BG, Krakauer T, Bonventre PF. Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide- potentiated mouse lethality model. Infect Immun 1995; 63:1229-34.
26. Robbins R, Gould S, Bergdoll M. Detecting the enterotoxigenicity of Staphylococcus aureus strains. Appl Microbiol 1974; 28:946-50.
27. Abrahmsen L, Dohlsten M, Segren S, Bjork P, Jonsson E, Kalland T. Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J 1995; 14:2978-86.
28. Krupka HI, Segelke BW, Ulrich RG, Ringhofer S, Knapp M, Rupp B. Structural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-II alpha. Protein Sci 2002; 11:642-51.
29. Tranter HS. Foodborne staphylococcal illness. Lancet 1990; 336:1044-6.
30. Wright A, Andrews PL, Titball RW. Induction of emetic, pyrexic, and behavioral effects of Staphylococcus aureus enterotoxin B in the ferret. Infect Immun 2000; 68:2386-9.
31. Hu DL, Zhu G, Mori F, et al. Staphylococcal enterotoxin induces emesis through increasing serotonin release in intestine and it is downregulated by cannabinoid receptor 1. Cell Microbiol 2007; 9:2267-77.
32. Jett M, Brinkley W, Neill R, Gemski P, Hunt R. Staphylococcus aureus enterotoxin B challenge of monkeys: correlation of plasma levels of arachidonic acid cascade products with occurrence of illness. Infect Immun 1990; 58:3494-9.
33. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:705-11.
34. + T cells by staphylococcal enterotoxin B. J Exp Med 1990; 172:1091-100.
35. Neill RJ, Jett M, Crane R, et al. Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures. Infect Immun 1996; 64:3007-15.
36. Bergdoll MS. Monkey feeding test for staphylococcal enterotoxin. Methods Enzymol 1988; 165:324-33.
37. Stiles JW, Denniston JC. Response of the rhesus monkey, Macaca mulatta, to continuously infused staphylococcal enterotoxin B. Lab Invest 1971; 25:617-25.
38. Schlievert PM. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol 2001; 108:S107-10.
39. LeClaire RD, Hunt RE, Bavari S. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect Immun 2002; 70:2278-81.
40. Nilsson IM, Patti JM, Bremell T, Hook M, Tarkowski A. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J Clin Invest 1998; 101:2640-9.
41. Meyer RF, Miller L, Bennett RW, MacMillan JD. Development of a monoclonal antibody capable of interacting with five serotypes of Staphylococcus aureus enterotoxin. Appl Environ Microbiol 1984; 47:283-7.
42. Bohach GA, Hovde CJ, Handley JP, Schlievert PM. Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies. Infect Immun 1988; 56:400-4.
43. Kum WW, Chow AW. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activities by a monoclonal antibody to toxic shock syndrome toxin-1. J Infect Dis 2001; 183:1739-48.